130 related articles for article (PubMed ID: 3771517)
1. Conformational transitions of the estrogen receptor monomer. Effects of estrogens, antiestrogen, and temperature.
Hansen JC; Gorski J
J Biol Chem; 1986 Oct; 261(30):13990-6. PubMed ID: 3771517
[TBL] [Abstract][Full Text] [Related]
2. Human estrogen receptor ligand activity inversion mutants: receptors that interpret antiestrogens as estrogens and estrogens as antiestrogens and discriminate among different antiestrogens.
Montano MM; Ekena K; Krueger KD; Keller AL; Katzenellenbogen BS
Mol Endocrinol; 1996 Mar; 10(3):230-42. PubMed ID: 8833652
[TBL] [Abstract][Full Text] [Related]
3. Conformational and electrostatic properties of unoccupied and liganded estrogen receptors determined by aqueous two-phase partitioning.
Hansen JC; Gorski J
Biochemistry; 1985 Oct; 24(22):6078-85. PubMed ID: 4084507
[TBL] [Abstract][Full Text] [Related]
4. Effects of pharmacological concentrations of estrogens on proliferation and cell cycle kinetics of human breast cancer cell lines in vitro.
Reddel RR; Sutherland RL
Cancer Res; 1987 Oct; 47(20):5323-9. PubMed ID: 3652038
[TBL] [Abstract][Full Text] [Related]
5. Regulation of estrogen and progestin receptor concentrations in an experimental rat prostatic carcinoma by estrogen, antiestrogen, and progesterone.
Mobbs BG; Johnson IE; DeSombre ER; Toth J; Hughes A
Cancer Res; 1987 May; 47(10):2645-51. PubMed ID: 3552202
[TBL] [Abstract][Full Text] [Related]
6. Differential inhibition of estrogen and antiestrogen binding to the estrogen receptor by diethylpyrocarbonate.
Borgna JL; Scali J
J Steroid Biochem; 1988 Oct; 31(4A):427-36. PubMed ID: 3050278
[TBL] [Abstract][Full Text] [Related]
7. Estrogen receptor (ER) modulators each induce distinct conformational changes in ER alpha and ER beta.
Paige LA; Christensen DJ; Grøn H; Norris JD; Gottlin EB; Padilla KM; Chang CY; Ballas LM; Hamilton PT; McDonnell DP; Fowlkes DM
Proc Natl Acad Sci U S A; 1999 Mar; 96(7):3999-4004. PubMed ID: 10097152
[TBL] [Abstract][Full Text] [Related]
8. Differential interactions of estrogens and antiestrogens at the 17 beta-hydroxy or counterpart function with the estrogen receptor.
Borgna JL; Scali J
Eur J Biochem; 1991 Aug; 199(3):575-85. PubMed ID: 1868844
[TBL] [Abstract][Full Text] [Related]
9. Structural basis for the deactivation of the estrogen-related receptor gamma by diethylstilbestrol or 4-hydroxytamoxifen and determinants of selectivity.
Greschik H; Flaig R; Renaud JP; Moras D
J Biol Chem; 2004 Aug; 279(32):33639-46. PubMed ID: 15161930
[TBL] [Abstract][Full Text] [Related]
10. Effects of antiestrogen versus antiprogestin on transformed and nontransformed steroid receptors.
Turner JW; Ruh MF; Ward DT; Ruh TS
J Steroid Biochem Mol Biol; 1991 Feb; 38(2):197-203. PubMed ID: 2004041
[TBL] [Abstract][Full Text] [Related]
11. Estrogen-receptor--DNA interaction. Difference between activation by estrogen and antiestrogen.
Evans E; Baskevitch PP; Rochefort H
Eur J Biochem; 1982 Nov; 128(1):185-91. PubMed ID: 7173202
[TBL] [Abstract][Full Text] [Related]
12. Probing the structure and function of the estrogen receptor ligand binding domain by analysis of mutants with altered transactivation characteristics.
Eng FC; Lee HS; Ferrara J; Willson TM; White JH
Mol Cell Biol; 1997 Aug; 17(8):4644-53. PubMed ID: 9234721
[TBL] [Abstract][Full Text] [Related]
13. Comparison of tamoxifen ligands on estrogen receptor interaction with estrogen response elements.
Klinge CM; Studinski-Jones AL; Kulakosky PC; Bambara RA; Hilf R
Mol Cell Endocrinol; 1998 Aug; 143(1-2):79-90. PubMed ID: 9806352
[TBL] [Abstract][Full Text] [Related]
14. Estrogenic and antiestrogenic regulation of the half-life of covalently labeled estrogen receptor in MCF-7 breast cancer cells.
Borrás M; Laios I; el Khissiin A; Seo HS; Lempereur F; Legros N; Leclercq G
J Steroid Biochem Mol Biol; 1996 Feb; 57(3-4):203-13. PubMed ID: 8645630
[TBL] [Abstract][Full Text] [Related]
15. A naturally occurring estrogen receptor mutation results in increased estrogenicity of a tamoxifen analog.
Catherino WH; Wolf DM; Jordan VC
Mol Endocrinol; 1995 Aug; 9(8):1053-63. PubMed ID: 7476979
[TBL] [Abstract][Full Text] [Related]
16. Various phosphorylation pathways, depending on agonist and antagonist binding to endogenous estrogen receptor alpha (ERalpha), differentially affect ERalpha extractability, proteasome-mediated stability, and transcriptional activity in human breast cancer cells.
Marsaud V; Gougelet A; Maillard S; Renoir JM
Mol Endocrinol; 2003 Oct; 17(10):2013-27. PubMed ID: 12855746
[TBL] [Abstract][Full Text] [Related]
17. Estrogen receptor beta activates the human retinoic acid receptor alpha-1 promoter in response to tamoxifen and other estrogen receptor antagonists, but not in response to estrogen.
Zou A; Marschke KB; Arnold KE; Berger EM; Fitzgerald P; Mais DE; Allegretto EA
Mol Endocrinol; 1999 Mar; 13(3):418-30. PubMed ID: 10076999
[TBL] [Abstract][Full Text] [Related]
18. Modulation of the ligand-independent activation of the human estrogen receptor by hormone and antihormone.
Smith CL; Conneely OM; O'Malley BW
Proc Natl Acad Sci U S A; 1993 Jul; 90(13):6120-4. PubMed ID: 8327492
[TBL] [Abstract][Full Text] [Related]
19. Both estradiol and tamoxifen decrease proliferation and invasiveness of cancer cells transfected with a mutated estrogen receptor.
Garcia M; Derocq D; Platet N; Bonnet S; Brouillet JP; Touitou I; Rochefort H
J Steroid Biochem Mol Biol; 1997 Apr; 61(1-2):11-7. PubMed ID: 9328205
[TBL] [Abstract][Full Text] [Related]
20. Comparison of the physicochemical properties of uterine nuclear estrogen receptors bound to estradiol or 4-hydroxytamoxifen.
Attardi B; Happe HK
Endocrinology; 1986 Aug; 119(2):904-15. PubMed ID: 3732150
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
